Sharemaestro Newsreel

SOPHiA GENETICS (NASDAQ:SOPH) Chairman Sells $138,400.00 in Stock

SOPHiA GENETICS Chairman Jurgi Camblong sold 20,000 shares of the company's stock for $138,400 under a pre-arranged Rule 10b5-1 plan, reducing his ownership by 0.57%. This insider sale comes amidst mixed quarterly results where revenue exceeded expectations but the company reported a larger-than-anticipated loss …

Tempus AI, Inc. (TEM) director sells 370 shares under 10b5-1 plan

Tempus AI, Inc. director David R. Epstein sold 370 shares of Class A Common Stock on August 3, 2026, at a price of $43.40 per share, under a pre-arranged Rule 10b5-1 trading plan adopted on August 27, 2024. Following this transaction, Epstein directly holds …

Tempus AI, Inc. (TEM) CEO's spouse sells 23,818 shares in plan

The spouse of Ryan Fukushima, CEO of Data at Tempus AI, Inc. (TEM), sold 23,818 shares of Class A Common Stock on August 3, 2026. These sales were conducted under a Rule 10b5-1 trading plan at weighted-average prices between $43.25 and $46.94. Following these …

SOPHiA GENETICS SA 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:SOPH) 2026-08-05

SOPHiA GENETICS SA (NASDAQ:SOPH) published its Q2 2026 earnings call presentation, reporting an EPS of -$0.20, which beat estimates by $0.02. The company also announced revenue of $23.31M, representing a 27.22% year-over-year increase and beating expectations by $1.60M. The slide deck was released in …

Schrodinger, Inc. 2026: Revenue $58.89M, EPS $0.08— 10-Q Summary

Schrodinger, Inc. reported strong financial results for the quarter ended 2026, achieving profitability with revenue of $58.89M and diluted EPS of $0.08. This marks a significant improvement from the prior-year quarter's $54.76M revenue and ($0.59) EPS. The growth was driven by drug discovery milestones …

Dimensional Fund Advisors LP Decreases Stake in Teladoc Health, Inc. $TDOC

Dimensional Fund Advisors LP significantly reduced its stake in Teladoc Health, Inc. by 16% in the first quarter, selling 1.2 million shares but still retaining over 6.3 million shares valued at approximately $34.3 million. Despite beating EPS estimates, Teladoc's revenue declined year-over-year and missed …

So-Young International names new CFO

So-Young International Inc. (SY.US) has appointed Shen Nan as its new CFO, effective August 3rd, replacing CEO Jin Xing who served as interim CFO. Shen Nan previously held the CFO position at Gaotu Techedu. The cosmetic surgery company reported a 45.8% increase in Q1 …

SOPHiA GENETICS Updates Investors With Q2 2026 Form 6-K Filing

SOPHiA GENETICS (SOPH) has filed its Q2 2026 Form 6-K with the SEC, which includes unaudited interim financial statements and management discussion. This filing provides transparency to investors regarding the company's financial performance and operational trends. While analysts rate SOPH as a Buy with …

LifeMD (NASDAQ: LFMD) posts $15.96M loss but holds $25.1M cash and $30M credit line

LifeMD, Inc. reported a Q2 2026 net loss of $15.96 million from continuing operations, despite revenues of $47.3 million, a slight decrease from the prior year. The company maintains a strong liquidity position with $25.1 million in cash, no outstanding debt, and an undrawn …

Wondering what's happening in today's after-hours session?

This article provides an overview of the top gainers and losers in the US after-hours trading session on Wednesday, August 5, 2026. It highlights several companies, including MANGOCEUTICALS INC (MGRX) and CREATIVE MEDICAL TECHNOLOGY (CELZ) as top gainers, and YXT.COM GROUP HOLDING LTD (YXT) …

Earnings call transcript: Schrödinger beats Q2 2026 forecasts as shares rise

Schrödinger (SDGR) significantly exceeded Q2 2026 earnings and revenue forecasts, reporting a profit of $0.08 per share against an expected loss and revenue of $58.9 million, above estimates. The company saw a 27% increase in annual contract value, driven by strong demand for its …

GoodRx Holdings (NASDAQ: GDRX) pivots as Rx revenue falls 26%

BMS to Deploy Schrödinger’s AI Co-Scientist for Drug Discovery

Schrödinger (Nasdaq: SDGR) announced a strategic agreement with Bristol Myers Squibb (BMS) to integrate Bunsen, Schrödinger's AI co-scientist, into BMS's research operations. This collaboration builds on an existing partnership, enhancing BMS's drug discovery process by leveraging Bunsen's capabilities for complex molecular exploration and accelerating …

Hinge Health (HNGE) Is Up 5.5% After Raising 2026 Outlook And Announcing Cylinder Deal

Hinge Health (HNGE) saw a 5.5% increase in stock value after reporting strong Q2 2026 revenues of US$212.82 million and net income of US$43.69 million, leading to raised full-year and Q3 2026 revenue guidance. The company also expanded its share repurchase program to US$550 …

Omnicell, Inc. (NASDAQ: OMCL) returns to profit with Q2 2026 growth

GoodRx’s Pharma Direct Revenue Rises 76% as Subscriptions Grow

Carlsmed® Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance

Carlsmed, Inc. announced strong financial results for the second quarter of 2026, including 57% year-over-year revenue growth to $18.9 million and expanded gross margins. The company also raised its full-year 2026 revenue guidance to $74-$78 million, citing strong volume growth for its aprevo® procedures …

OMNICELL, INC. 2026: Revenue $312.21M, EPS $0.52— 10-Q Summary

Omnicell, Inc. (OMCL) reported strong financial results for the quarter ended 2026, with revenue reaching $312.21M and diluted EPS of $0.52. This growth was driven by increased product and service sales, improved margins, and strategic shifts towards platform offerings and recurring revenue. The company …

Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development

Mangoceuticals' merger partner, Nuclea Energy, has signed a Memorandum of Understanding (MOU) with the Utah Office of Energy Development to explore siting a nuclear test reactor for its Morpheus microreactor at the Utah San Rafael Energy Lab. This partnership aims to advance the research, …

PHR Stockholders Have Opportunity to Lead Phreesia, Inc. Class Ac

Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Phreesia, Inc. (NYSE:PHR) and certain officers, alleging federal securities law violations. The lawsuit claims that Phreesia made false and misleading statements regarding slowing demand, diminished revenue visibility, and weakened pharmaceutical marketing commitments …

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Teladoc Health, Inc. (TDOC) And Encourages Investors to Reach Out

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Teladoc Health, Inc. (TDOC) following the company's Q2 2026 financial results, which reported lower-than-expected revenue and a reduced full-year guidance. The investigation focuses on potential claims for investors who purchased Teladoc Health securities, especially …

Amwell raises 2026 revenue floor to $200M after Q2 report

Amwell (NYSE: AMWL) reported strong Q2 2026 results, with $52.0 million in revenue, at the top of its guidance, and an improved adjusted EBITDA loss of ($1.2) million. Following this performance, the company raised the low end of its 2026 revenue outlook to $200–$205 …

Health Catalyst (HCAT) Q2 Earnings Report Preview: What To Look For

Health Catalyst (HCAT) is set to report its Q2 earnings, with analysts expecting a 14.6% year-on-year revenue decline. The company beat revenue expectations last quarter but issued slower guidance. While the data and analytics software segment has shown positive investor sentiment, Health Catalyst's stock …

HealthStream (HSTM) Stock Price Climbs As Rich Valuation Draws Focus

HealthStream's stock (HSTM) rose by 5% following strong Q2 2026 results, with revenue up 12.5% and EPS increasing. While the company demonstrates strong platform traction and recurring revenue growth, its high P/E ratio near 41x and 6.6% net margin raise questions about its valuation. …

Understanding the Setup: (AMWL) and Scalable Risk

This article provides an AI-driven analysis of American Well Corporation Class A (NASDAQ: AMWL), highlighting a weak near-term sentiment but potential long-term strength. It details specific trading strategies—position trading, momentum breakout, and risk hedging—with entry zones, targets, and stop losses. The analysis also includes …

Heartflow Inc (HTFL) Earnings Forecast: Future EPS & Revenue Growth Estimates

Heartflow Inc (HTFL) has an earnings forecast score of 8.44 and an average price target of $40.00, with analysts largely recommending a "Buy." The company's expected revenue for the next quarter is $56.64 million, and its EPS for the previous quarter was -$0.29, with …

Discipline and Rules-Based Execution in WAY Response

This article analyzes Waystar Holding Corp. (NYSE: WAY), noting weak sentiment that may indicate a resumption of long-term weakness. It identifies no clear price positioning signal but points to compelling upside potential due to the absence of resistance levels above the current price. The …

Privia Health earnings in focus: Can profit rebound after Q1 miss?

Privia Health Group Inc. is set to report its second-quarter earnings, with analysts expecting a significant rebound in profit to 7 cents per share after a disappointing first quarter. Investors will be focused on whether the company can demonstrate sustainable profitability, continued revenue growth, …

SOPHiA GENETICS (NASDAQ:SOPH) Hits New 52-Week High After Analyst Upgrade

SOPHiA GENETICS (NASDAQ:SOPH) reached a new 52-week high following an analyst upgrade from BTIG Research, which raised its price target from $8 to $9 and maintained a Buy rating. The company reported strong Q2 2026 revenue of $23.3 million, a 27% year-over-year increase, and …

Investors brace for Schrodinger earnings amid model shift By Investing.com

Schrodinger Inc. is set to release its second-quarter earnings, with investors closely watching its progress in drug discovery collaborations and its transition to a hosted software licensing model. Analysts anticipate a loss of 39 cents per share on $47.4 million in revenue, a sequential …

CARL Stock Price and Chart — NASDAQ:CARL

This article provides a comprehensive overview of Carlsmed, Inc. (CARL) stock, including its current price, historical performance, key financial metrics, and analyst forecasts. It highlights the company's Q2 2026 earnings, revenue growth driven by surgeon adoption, and increased full-year revenue guidance. The article also …

sophia genetics sa Positive Earnings Pre-Announcements

SOPHiA GENETICS SA has pre-announced positive earnings, with estimated FY26 revenue now ranging from $94-$96 Million, an increase from the previous estimate of $92-$94 Million. This positive revision is part of a broader trend of news surrounding the company's collaborations and financial performance. The …

BTIG Research Issues Positive Forecast for SOPHiA GENETICS (NASDAQ:SOPH) Stock Price

BTIG Research has raised its price target for SOPHiA GENETICS (NASDAQ:SOPH) to $9.00 from $8.00, maintaining a "buy" rating and suggesting a 31.58% upside. This positive outlook follows the company's Q2 2026 revenue beat, an increased full-year revenue outlook of $94 million-$96 million, and …

BTIG raises Sophia Genetics stock price target on CDx deals

BTIG has increased its price target for Sophia Genetics SA (NASDAQ:SOPH) to $9.00 from $8.00, maintaining a Buy rating, following the company's better-than-expected second-quarter results and two new companion diagnostics deals with AstraZeneca. Sophia Genetics reported 27% revenue growth, driven by volume increases and …

Waystar Holding Corp. (WAY) Stock Price, News, Quote & History

This article provides comprehensive financial data for Waystar Holding Corp. (WAY), including its current stock price, performance metrics, key statistics, and analyst insights. It details the company's overview as a healthcare information services provider and offers comparisons with similar companies in the industry.

10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect